2022 Oncology State of the Union

Complimentary resource

In this year’s Oncology State of the Union, we examine the most important strategic questions facing oncology leaders across the industry during the peri-Covid-19 era. While the pandemic has had very real—and at times painful—consequences already, many of the decisions that will shape the future of oncology have yet to be made.

Download the preview of our slides where we focus on what the future of drug spending will be and how oncology leaders can influence it.

About Advisory Board

For over 40 years, Advisory Board has researched health care's top challenges to provide leaders with the strategic guidance needed to push the industry forward. Our team of nearly 200 experts serves over 4,500 organizations that include hospitals, health systems, post-acute care providers, physician groups, life sciences firms, digital health companies, and health plans and more. Learn more at advisory.com/about-us.

Download now

First Name*

Last Name*

Email*

Please enter a valid email address

Company*

Job Title*

Management Level*

City*

State or Province*

Country*

Business Phone

Contact me with more information about Advisory Board's oncology resources.

Advisory Board uses the information you provide to contact you about our related content and services. You may unsubscribe from these communications at any time. For more information, check out our privacy policy.